Search filters

Filters
Clear All

Phase

  • 4
  • 1
  • 1
  • 2
  • 3
  • 13
  • 6
  • 13

Found 13 Duodenal Ulcers trials

A listing of Duodenal Ulcers medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

 Safety and Efficacy of IONIS-FB-Lrx in Patients  With Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration (AMD)
55 years - 99 years
All genders
Phase 3
Interventional
The purpose of this study is to assess the Safety and Efficacy of IONIS-FB-Lrx patients with Geographic Atrophy secondary to Age Related Macular Degeneration
 Study to Evaluate the Safety and Efficacy of CSB-001 Ophthalmic Solution 0.1% in Stage 2 and 3 Neurotrophic Keratitis Subjects
18 years - 99 years
All genders
Phase 1
Interventional
The purpose of this study is to compare the safety and effectiveness of the study product, CSB-001 ophthalmic solution 0.1% to placebo when treating stage 2 and 3 Neurotrophic Keratitis.
99 years or below
All genders
Many patients suffer from acute ocular pain due to different problems, however there is no available treatment for chronic eye pain (long lasting eye pain). Very often eye pain is reported after surgical procedures, like PRK and LASIK. Up to 60% of patients continue to have chronic pain beyond one …
18 years - 99 years
All genders
Interventional
This study seeks to find out whether an oral medication called Fenofibrate can slow or prevent worsening of diabetic retinopathy.
18 years - 99 years
All genders
The purpose of this study is to find out about the safety and efficacy of T4032, which is a preservative-free formulation of bimatoprost (0.01%) for the treatment of glaucoma or ocular (eye) hypertension. There will be 5 to 6 study visits and participation will last up to 12 weeks (120 …
99 years or below
All genders
The ADalimumab Vs. conventional ImmunoSupprEssion for uveitis (ADVISE) Trial is a randomized, comparative effectiveness trial comparing adalimumab to conventional agent immunosuppression for patients with non-infectious, intermediate, posterior, and panuveitides. Scheie Eye Institute, the Department of Ophthalmology, University of Pennsylvania will not enroll any patients under 18 years of age.
 PPS Study- Screening and Classification of Pentosan-Associated Maculopathy in Patients with Interstitial Cystitis
18 years - 99 years
All genders
The primary objective of this study is to determine the prevalence of retinal changes in patients using pentosan polysulfate sodium (PPS) for treatment of interstitial cystitis and further characterize this condition using multimodal imaging. Additionally, this study aims to identify additional clinical findings associated with PPS maculopathy and to gain …
 Observational Characterization of the Treatment Course of Patients With Thyroid Eye Disease
18 years - 99 years
All genders
This study will: • Evaluate standard-of-care (SOC) treatment for TED in a real-world setting • Evaluate effectiveness of the treatment in terms of protrusion of the eyeball (proptosis) • Show if the SOC treatment has any effect on eye anatomy and function and fi the appearance of the subject’s eyes …
70 years - 99 years
All genders
Phase 2
Interventional
This study will test danicopan, a new drug that is being developed by Alexion to slow down progression of GA. The goals of this study are as follows: • To find out whether danicopan can slow the rate of GA disease progression, and in turn slow the loss of visual …
99 years or below
All genders
This randomized clinical trial will evaluate the effect of tonabersat compared with placebo on central subfield thickness (CST) in eyes with center-involved DME and good visual acuity.
1 - 10 of 13